Detalhe da pesquisa
1.
Direct Preparation of *MRE Zeolites with Ultralarge Mesoporosity: Strategy and Working Mechanism.
ACS Appl Mater Interfaces;
13(27): 31756-31765, 2021 Jul 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34192458
2.
Development of Highly Optimized Antibody-Drug Conjugates against CD33 and CD123 for Acute Myeloid Leukemia.
Clin Cancer Res;
27(2): 622-631, 2021 01 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33148666
3.
A Novel GUCY2C-CD3 T-Cell Engaging Bispecific Construct (PF-07062119) for the Treatment of Gastrointestinal Cancers.
Clin Cancer Res;
26(9): 2188-2202, 2020 05 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31996389
4.
Getting zeolite catalysts to play your tune: methyl carboxylate esters as switchable promoters for methanol dehydration to DME.
Chem Commun (Camb);
55(92): 13804-13807, 2019 Nov 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31633709
5.
Caveolae-Mediated Endocytosis as a Novel Mechanism of Resistance to Trastuzumab Emtansine (T-DM1).
Mol Cancer Ther;
17(1): 243-253, 2018 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29054985
6.
Paclitaxel-resistant cells have a mutation in the paclitaxel-binding region of beta-tubulin (Asp26Glu) and less stable microtubules.
Mol Cancer Ther;
5(2): 270-8, 2006 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16505100
7.
Multivalent peptidic linker enables identification of preferred sites of conjugation for a potent thialanstatin antibody drug conjugate.
PLoS One;
12(5): e0178452, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28558059
8.
HTI-286, a synthetic analogue of the tripeptide hemiasterlin, is a potent antimicrotubule agent that circumvents P-glycoprotein-mediated resistance in vitro and in vivo.
Cancer Res;
63(8): 1838-45, 2003 Apr 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12702571
9.
2-(Quinazolin-4-ylamino)-[1,4]benzoquinones as covalent-binding, irreversible inhibitors of the kinase domain of vascular endothelial growth factor receptor-2.
J Med Chem;
48(24): 7560-81, 2005 Dec 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16302797
10.
Mutagenic specificity of 2-acetylaminonaphthalene-derived DNA adduct in mammalian cells.
Chem Biol Interact;
152(2-3): 131-8, 2005 Apr 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15840386
11.
MAC-321, a novel taxane with greater efficacy than paclitaxel and docetaxel in vitro and in vivo.
Mol Cancer Ther;
2(9): 873-84, 2003 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-14555706
12.
Cells resistant to HTI-286 do not overexpress P-glycoprotein but have reduced drug accumulation and a point mutation in alpha-tubulin.
Mol Cancer Ther;
3(10): 1319-27, 2004 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15486199
13.
Tumor cells chronically treated with a trastuzumab-maytansinoid antibody-drug conjugate develop varied resistance mechanisms but respond to alternate treatments.
Mol Cancer Ther;
14(4): 952-63, 2015 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25646013
14.
Dual irreversible kinase inhibitors: quinazoline-based inhibitors incorporating two independent reactive centers with each targeting different cysteine residues in the kinase domains of EGFR and VEGFR-2.
Bioorg Med Chem;
15(11): 3635-48, 2007 Jun 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17416531
15.
Mutagenic events in Escherichia coli and mammalian cells generated in response to acetylaminofluorene-derived DNA adducts positioned in the Nar I restriction enzyme site.
Biochemistry;
41(48): 14255-62, 2002 Dec 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12450390